At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...

Cancer is increasingly recognized as a systemic disease influenced by complex interactions between genetic, metabolic, immunologic, and environmental ...

A new discovery from the lab of YouYang Zhao, Ph.D., from Stanley Manne Children's Research Institute at Ann & Robert H.

Research will focus on the genome-wide identification of microexons to advance the knowledge on gene functions.

New research details blueberry genes that control plant hormones, key for growth & fruit size. Scientists identified 361 ...

Cells are regularly faced with environmental stresses that may damage or destroy them. To survive, they quickly adjust their ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update R&D Day Highlights Potential for IMNN-001 On November 10, 2025, ...

NOVEMBER 17, 2025, NEW YORK - Like all hardworking things, the cytotoxic T lymphocytes (CTLs) of the immune system charged ...

Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems for the acceleration of partners' clinical development, recently presented its Next-Generation LNP advancements, a ...

As the days continue to get shorter, scientists have made a significant discovery in understanding exactly what makes mammals ...

CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...